PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PDS Biotechnology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7582
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunotherapies and t-cell vaccines. Its products are used for treatment of HPV pre-cancer, ovarian cancer, pandemic influenza, head and neck cancer, cervical cancer and breast cancer, among others. PDS Biotechnology also partners with cancer research institutes and biotechnology companies. The company offers its products across the US. PDS Biotechnology is headquartered in North Brunswick, New Jersey, the US.

PDS Biotechnology Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PDS Biotech Raises USD1 Million in Venture Financing 10
PDS Biotech Raises Funds Through Venture Financing 11
Private Equity 12
NetScientific Invests in PDS Biotech 12
Partnerships 13
PDS Biotech Enters into Agreement with Merck 13
PDS Biotechnology Enters into R&D Agreement with National Cancer Institute 14
Licensing Agreements 15
PDS Biotechnology Enters Into Licensing Agreement With Merck For Versamune 15
PDS Biotechnology Corp – Key Competitors 16
PDS Biotechnology Corp – Key Employees 17
PDS Biotechnology Corp – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Key Facts 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PDS Biotechnology Corp, Deals By Therapy Area, 2012 to YTD 2018 8
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PDS Biotech Raises USD1 Million in Venture Financing 10
PDS Biotech Raises Funds Through Venture Financing 11
NetScientific Invests in PDS Biotech 12
PDS Biotech Enters into Agreement with Merck 13
PDS Biotechnology Enters into R&D Agreement with National Cancer Institute 14
PDS Biotechnology Enters Into Licensing Agreement With Merck For Versamune 15
PDS Biotechnology Corp, Key Competitors 16
PDS Biotechnology Corp, Key Employees 17

List of Figures
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apex Oil Company, Inc.:企業の戦略・SWOT・財務分析
    Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Centerra Gold Inc.:企業の戦略・SWOT・財務情報
    Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Future Fund:企業の戦略的SWOT分析
    Future Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Borr Drilling Ltd (BDRILL):石油・ガス:M&Aディール及び事業提携情報
    Summary Borr Drilling Ltd (Borr Drilling) is a provider of drilling services for offshore oil and gas industry. The company owns and operates modern jack-up drilling rigs and deliver drilling operations in hydrocarbon basins around the globe. It has operational presence in Norway, Bermuda and the UA …
  • Mid-America Apartment Communities Inc (MAA):企業の財務・戦略的SWOT分析
    Summary Mid-America Apartment Communities, Inc. (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven suppo …
  • Vicat SA:企業の戦略・SWOT・財務情報
    Vicat SA - Strategy, SWOT and Corporate Finance Report Summary Vicat SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Intesa Sanpaolo S.p.A:企業のM&A・事業提携・投資動向
    Intesa Sanpaolo S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intesa Sanpaolo S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Chromatin Inc:企業のM&A・事業提携・投資動向
    Chromatin Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chromatin Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Cell Signaling Technology Inc-医療機器分野:企業M&A・提携分析
    Summary Cell Signaling Technology Inc (CST) is a biotechnology company that develops and manufactures antibody products for medical research and clinical diagnostic market. The company products include primary antibodies, antibody samplers, secondary antibodies, antibody conjugates, ELISA Kits, anti …
  • The British United Provident Association Limited :企業の戦略・SWOT・財務情報
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Showa Shell Sekiyu KK (5002):電力:M&Aディール及び事業提携情報
    Summary Showa Shell Sekiyu KK (Showa Shell) is an energy company. It mainly manufactures and sells oil products and energy related products, such as solar cell products and electricity. The company procures crude oil, refines, stores and sells petroleum products. Its product portfolio includes gasol …
  • Diebold Nixdorf, Incorporated:企業の戦略・SWOT・財務情報
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):企業の財務・戦略的SWOT分析
    Summary Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, p …
  • Anadolubank A.S.:企業の戦略・SWOT・財務情報
    Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • LifeVantage Corp (LFVN):企業の財務・戦略的SWOT分析
    Summary LifeVantage Corp (LifeVantage) is a science-based nutraceutical company that manufactures and markets dietary supplements. The company offers products such as protandim, axio, physiq, truescience and canine health, among others. Its beauty products include cleansers, hand creams, micro lift, …
  • Playboy Enterprises Inc:企業の戦略的SWOT分析
    Playboy Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • ProPhotonix Limited (PPIX):企業の財務・戦略的SWOT分析
    ProPhotonix Limited (PPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Inox Wind Ltd (INOXWIND):企業の財務・戦略的SWOT分析
    Inox Wind Ltd (INOXWIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Yanzhou Coal Mining Co Ltd:戦略・SWOT・企業財務分析
    Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Falck Renewables SpA (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables SpA (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆